Sickle Cell Amenia

BY: John Petty

1. Name Of Disorder?

This is the Sickle Cell Anemia. Other names are hemoglobin S Disease, and Sickle cell disorder.

2. What causes the disorder?

It is caused by inherited abnormal hemoglobin.

3. What gene or Chromosome is affected by this disorder? (X,Y,21)

It affects chromosome 11.

4. Are there prenatal tests for this disorder?

Yes, If the parents believe they are carriers they can talk to a genetic counselor and get Amniocentesis.

5. What are the symptoms?

You could have pain in joints, your whole body could be dizzy fatigue, low oxygen in the body.

6. What population is affected.

only the people who have through passed down genes.

7. Can anyone be a candidate for the disorder?

No it is genetic.

8. How is it inherited? (Is it sex-linked, recessive, and/or dominant?)

It is recessive.

9. What kind of medical assistance will the affected child need?

  • Daily antibiotics from 2 months to 5 years of age to prevent life-threatening infections. This practice stops at age 5 because older children don't have as many severe infections. Multivitamin supplements with iron during infancy. Folic acid supplements daily. Protein supplements if there is a lag in weight gain.

10. Will further assistance be needed, as the child grows older?

Will need to take the medication.

11. What is the long-term outlook for the child?

They have a low chance of healing but they will have to be weary of the problem.

12. Are there any treatments or cures?

No, Just ways to control the symptoms.

13. Could this disorder have been prevented?

You can prevent only some of the disease but not all of it.

14. Can this individual have children in the future?

Yes.

15. Will those children be affected?

Not if the one they marry has it .

16. What is the current status of research on this disorder?

They haven't found a cure for it but they have ways to prevent this.

17. Is there a cure/new treatment coming soon?

Hopefully but not as we know of.

18. Any other information you believe is relevant and needs to be included in your presentation.

No.

Works cited



Baltimore, David, et al. "On human gene editing: international summit statement by the organizing committee." Issues in Science and Technology 32.3 (2016): 55+. Student Resources in Context. Web. 5 May 2016.

URL
http://go.galegroup.com/ps/i.do?id=GALE%7CA451148623&v=2.1&u=roch2123&it=r&p=GPS&sw=w&asid=1d201981d17ddbf52d82051ba5735b97





Miller, Henry I. "Germline gene therapy: don't let good intentions spawn bad policy: the proposed moratorium on clinical applications of gene editing technology reveals ignorance about how innovation works, and callousness about human suffering." Issues in Science and Technology 32.3 (2016): 57+. Student Resources in Context. Web. 5 May 2016.

URL
http://go.galegroup.com/ps/i.do?id=GALE%7CA451148624&v=2.1&u=roch2123&it=r&p=GPS&sw=w&asid=cd42889d0fb0dadef00d41124e0c99ec







"Atutur Hospital Opens Clinic for Sickle Cell Patients." Africa News Service 4 May 2016. Student Resources in Context. Web. 5 May 2016.

URL
http://go.galegroup.com/ps/i.do?id=GALE%7CA451318433&v=2.1&u=roch2123&it=r&p=GPS&sw=w&asid=f4ec3069323c2079a302c030d7d4c70e





"Uncertainty Looms Over Sickle Cell Care." Africa News Service 27 Apr. 2016. Student Resources in Context. Web. 5 May 2016.

URL
http://go.galegroup.com/ps/i.do?id=GALE%7CA450685677&v=2.1&u=roch2123&it=r&p=GPS&sw=w&asid=c142386de55c47fa371bf03a11c2b789